Do you want to read an article? Please log in or register.
Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy
Retinal Diseases
Related content
Macular DiseasesRetinal Diseases
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial
JAMA Ophthalmol
Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P
doi: 10.1001/jamaophthalmol.2025.0001
Retinal Diseases
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial
JAMA Ophthalmol
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group
doi: 10.1001/jamaophthalmol.2025.3819
Macular DiseasesRetinal Diseases
Artificial intelligence-based fluid quantification predicts clinical outcomes in diabetic macular oedema eyes treated with intravitreal dexamethasone implants: DIADEMA project
Br J Ophthalmol
Franquesa-Garcia F, Romero-Nuñez B, Martin-Pinardel R, De Zanet S, González-López JJ, Escobar-Barranco JJ, Ruiz-Del-Tiempo MP, Boixadera A, Fonollosa A, Gómez-Benlloch A, Velazquez-Villoria D, Fernández-Vigo JI, Garay-Aramburu G, Parrado-Carrillo A, Castillon L, Gómez Sánchez S, Lavid FJ, Arruabarrena C, Figueras-Roca M, Bernal-Morales C, Ciller C, Zarranz-Ventura J, DIADEMA investigators
doi: 10.1136/bjo-2025-328172
Macular Diseases
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report
BMJ Open Ophthalmol
Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K
doi: 10.1136/bmjophth-2025-002467
Macular DiseasesRetinal Diseases
Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration
Acta Ophthalmol
Viggiano P, Santoro M, Boscia G, Porreca A, Borrelli E, Bacherini D, Lombardi L, Fumarola R, Grassi MO, Termite AC, Reibaldi M, Alessio G, Sadda S, Boscia F
doi: 10.1111/aos.17502
Retinal Diseases
Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand
Pediatr Diabetes
Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL
doi: 10.1155/2024/5893771
Retinal Diseases
Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study
Diabetes Obes Metab
Lavens A, De Block C, Oriot P, Philips JC, Vandenbroucke M, Crenier L, Nobels F, Mathieu C, Belgian Group of Experts IQED
doi: 10.1111/dom.70049
COMMENTED
Retinal Diseases
Relationship between free fatty acids and diabetic retinopathy in male patients with type 2 diabetes
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Sci Rep
Chen J, Huang Y, Liu C, Chi J, Xu L, Wang Y
doi: 10.1038/s41598-025-07001-w
Retinal Diseases
Development and validation of a risk prediction model for diabetic kidney disease in patients with diabetic retinopathy
Front Endocrinol (Lausanne)
Yin M, Dong W, Ren L, Han M, Wang G, Wang Y, Gang X
doi: 10.3389/fendo.2025.1499866